Countries citing papers authored by Daniel B. Roth
Since
Specialization
Citations
This map shows the geographic impact of Daniel B. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel B. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel B. Roth more than expected).
This network shows the impact of papers produced by Daniel B. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel B. Roth. The network helps show where Daniel B. Roth may publish in the future.
Co-authorship network of co-authors of Daniel B. Roth
This figure shows the co-authorship network connecting the top 25 collaborators of Daniel B. Roth.
A scholar is included among the top collaborators of Daniel B. Roth based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Daniel B. Roth. Daniel B. Roth is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Roth, Daniel B., et al.. (2014). Predictors of Success with Intravitreal Ocriplasmin in the Treatment of Symptomatic Vitreomacular Adhesion. Investigative Ophthalmology & Visual Science. 55(13). 298–298.3 indexed citations
5.
Shah, Sumit P., et al.. (2014). Postmarketing Surveillance Survey of Adverse Events of Ocriplasmin (Jetrea. Investigative Ophthalmology & Visual Science. 55(13). 2208–2208.2 indexed citations
6.
Roth, Daniel B., et al.. (2014). Complications of Intravitreal Ocriplasmin in the Treatment of Symptomatic Vitreomacular Adhesion. Investigative Ophthalmology & Visual Science. 55(13). 308–308.1 indexed citations
Prenner, Jonathan L., et al.. (2012). Incidence of Steroid Induced Ocular Hypertension Following Vitreoretinal Surgery With Difluprednate Versus Prednisolone Acetate. Investigative Ophthalmology & Visual Science. 53(14). 5383–5383.1 indexed citations
Roth, Daniel B., et al.. (2010). Factors Associated With Success or Failure After Retinal Detachment Surgery. Investigative Ophthalmology & Visual Science. 51(13). 6062–6062.
13.
Walsh, Mark K., T. Hassan, Lawrence S. Halperin, et al.. (2009). Multicenter Study of Endophthalmitis After Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents. Investigative Ophthalmology & Visual Science. 50(13). 6185–6185.1 indexed citations
14.
Roth, Daniel B., et al.. (2007). The Incidence of Systemic Adverse Events in Patients Treated With Intravitreal Bevacizumab (Avastin). Investigative Ophthalmology & Visual Science. 48(13). 4939–4939.1 indexed citations
15.
Roth, Daniel B., et al.. (2006). Early Clinical Experience with Pegaptanib Sodium (Macugen) in Age–Related Macular Degeneration. Investigative Ophthalmology & Visual Science. 47(13). 2149–2149.1 indexed citations
16.
Roth, Daniel B., et al.. (2005). Treatment of Refractory Post–operative Cystoid Macular Edema (CME) With Intravitreal Triamcinolone. Investigative Ophthalmology & Visual Science. 46(13). 1455–1455.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.